Employers have the greatest potential to influence drug prices by being much more aggressive in getting PBMs and payers to have skin in the drug-pricing game.
read full article ›Employers have the greatest potential to influence drug prices by being much more aggressive in getting PBMs and payers to have skin in the drug-pricing game.
read full article ›A new, structured approach to bringing value-based reimbursement models into the mainstream is outlined, thus transforming reimbursement and fueling the shift from volume to value.
read full article ›